Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation.
Leukemia ( IF 12.8 ) Pub Date : 2020-02-24 , DOI: 10.1038/s41375-020-0769-1
Julius Lukes _{1, 2} , Petr Danek ₃ , Oriol Alejo-Valle ₄ , Eliska Potuckova _{1, 2} , Ondrej Gahura ₅ , Dirk Heckl ₄ , Julia Starkova _{1, 2} , Jan Stary _{2, 6} , Ester Mejstrikova _{1, 2, 6} , Meritxell Alberich-Jorda _{1, 3} , Jan Zuna _{1, 2, 6} , Jan Trka _{1, 2, 6} , Jan-Henning Klusmann ₄ , Marketa Zaliova _{1, 2, 6}

更新日期：2020-02-25